The Prospects of Vitamin C in Cancer Therapy

키워드

참고문헌 (63)

1. Cameron E, "Ascorbic acid and cancer:a review", Cancer Res, 39, pp.663~681 (1979)
2. Golde DW, "Vitamin C in cancer", Integr Cancer Ther, 2, pp.158~159 (2003)
3. Cameron E, "Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer", Proc Natl Acad Sci U S A, 75, pp.4538~4542 (1978)
4. Padayatty SJ, "Reevaluation of ascorbate in cancer treatment: emerqing evidence, open minds and serendipity", J Am Coll Nutr, 19, pp.423~425 (2000)
5. Creagan ET, "Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer", N Engl J Med, 301, pp.687~690 (1979)
6. Moertel CG, "High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison", N Engl J Med, 312, pp.137~141 (1985)
7. Wittes RE, "Vitamin C and cancer", N Engl J Med, 312, pp.178~179 (1985)
8. McCormick WJ, "the preconditioning factor in pathogenesis; a new etiologic approach", Arch Pediatr, 70, pp.313~322 (1954)
9. McCormick WJ, "Cancer: a collagen disease, secondary to a nutritional deficiency", Arch Pediatr, 76, pp.166~171 (1959)
10. Cameron E, "Ascorbic acid, cell proliferation, and cancer", Lancet, 1, pp.542~ (1972)
11. Cameron E, "Ascorbic acid and the glycosaminoglycans.An orthomolecular approach to cancer and other diseases", Oncology, 27, pp.181~192 (1973)
12. Cameron E, "The orthomolecular treatment of cancer, II: clinical trial of high-dose ascorbic acid supplements in advanced human cancer", Chem Biol Interact, 9, pp.285~315 (1974)
13. Cameron E, "Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer", Proc Natl Acad Sci U S A, 73, pp.3685~3689 (1976)
14. Head KA, "Ascobic acid in the prevention and treatment of cancer", Altern Med Rev, 3, pp.174~186 (1998)
15. Cameron E, "Innovation vs. quality control:an ‘unpublishable’ clinical trial of supplemental ascorbate in incurable cancer", Med Hypotheses, 36, pp.185~189 (1991)
16. Graumlich JF, "Pharmacokinetics model of ascorbic acid in healthy male volunteers during depletion and repletion", Pharm Res, 14, pp.1133~1139 (1997)
17. Satoshi O, "High-dose vitamin C (Ascorbic acid) therapy in the treatment of patient with advanced cancer", Anticancer Res, 29, pp.809~816 (2009)
18. Keith I, "Vitamin C in alternative cancer treatment: Historical background", Integrative Cancer Therapies, 2, pp.147~154 (2003)
19. González MJ, "Orthomolecular oncology review: ascorbic acid and cancer 25 years later", Interg cancer therapies, 4, pp.32~44 (2005)
20. Levine M, "New concepts in the biology and biochemistry of ascorbic acid", N Engl J Med, 314, pp.892~902 (1986)
21. Block G, "Vitamin C and cancer prevention: the epidemiologic evidence", Am J Clin Nutr, 53, pp.s270~282 (1991)
22. Rebouche CJ, "Ascorbic acid and carnitine biosynthesis", Am J Clin Nutr, 54, pp.s1147~1152 (1991)
23. Englard S, "The biochemical functions of ascorbic acid", Annu Rev Nutr, 6, pp.365~406 (1986)
24. Sies H, "Antioxidant functions of vitamins in Vitamins E and C, beta-carotene and other carotenioids", Ann N Y Acad Sci, 669, pp.7~20 (1992)
25. Niki E, "Action of ascorbic acid as a scavenger of active and stable oxygen radicals", Am J Clin Nutr, 54, pp.1119~1124 (1991)
26. Frei B, "Ascorbate is an outstanding antioxidant in human blood plasma", Proc Natl Acad Sci, 86, pp.6377~6381 (1989)
27. Ramp WK, "The effects of ascorbic acid on the glycolytic and respiratory metabolism of embryonic chick tibias", Calcif Tissue Res, 2, pp.77~82 (1968)
28. Mikino Y, "Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines", Anticancer Res, 19, pp.3125~3132 (1999)
29. Poydock ME, "Inhibiting effect of dehydroascorbic acid on cell division in ascites tumors in mice", Exp Cell Biol, 50, pp.34~38 (1982)
30. Tomita Y, "Antitumor potency of 3-methyl-3,4-dihydroxytetrone", Sci Bull Fac Agr Kyushu Univ, 28, pp.131~137 (1974)
31. Gonzalez MJ, "Rethinking vitamin C and cancer: an uptake on nutritional oncology", Cancer Prev Int, 3, pp.215~224 (1998)
32. Jampel HD, "Ascorbic acid is cytotoxic to dividing human Tenon’s capsule fibroblasts. A possible contributing factor in glaucoma filtration surgery success", Arch Ophthalmol, 108, pp.1323~1325 (1990)
33. Tsao CS, "In vivo antineoplastic activity of ascorbic acid for human mammary tumor", In vivo, 2, pp.147~150 (1988)
34. Tsao CS, "Effect of ascorbic acid and its derivatives on the growth of human mammary tumor xenografts in mice", Cancer J, 5, pp.53~59 (1989)
35. Bram S, "Vitamin C preferential toxicity for malignant melanoma cells", Nature, 284, pp.629~631 (1980)
36. Sies H, "Vitamin E and C, beta-carotene, and other carotenoids as antioxidants", Am J Clin Nutr, 62, pp.1315~1321 (1995)
37. Hemila H, "Vitamin C and the common cold", Br J Nutr, 67, pp.3~16 (1992)
38. Jeng KC, "Supplementation with vitamin C and E enhances cytokine production by peripheral blood mononuclear cells in heathly adults", Am J Clin Nutr, 64, pp.960~965 (1996)
39. Cho D, "Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signaling in B16F10 murine melanoma cells", Melano Res, 13, pp.549~554 (2003)
40. Okamura H, "Cloning of a new cytokine that induces IFN-gamma production by T cells", Nature, 378, pp.88~91 (1995)
41. Park HU, "Enhanced IL-18 expression in common skin tumors", Immunol Lett, 79, pp.215~219 (2001)
42. Kim KE, "Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines", Oncogene, 26, pp.1468~1476 (2007)
43. Park S, "Interleukin-18 induces transferrin expression in breast cancer cell line MCF-7", Cancer Lett (2009)
44. Park S, "The dual effects of interleukin-18 in tumor progression", Cell & Mol Immunol, 4, pp.329~335 (2007)
45. Vera JC, "Mammalian facilitative hexose transports mediate the transport of dehydroascorbic acid", Nature, 364, pp.79~82 (1993)
46. Vera JC, "Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid", Blood, 84, pp.1628~1634
47. Guaiquil VH, "Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione", J Biol Chem, 272, pp.9915~9921 (1997)
48. Guaiquil VH, "Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells", J Biol Chem, 276, pp.40955~40961 (2001)
49. Galleano M, "Ascorbyl radical", ascorbate ratio in plasma from iron overloaded rats as oxidative stress indicator, 2002, pp.133, 193~201
50. Heaney ML, "Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs", Cancer Res, 68, pp.8031~8038 (2008)
51. Lee SH, "Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins", Science, 292, pp.2083~2086 (2001)
52. Lee KW, "Vitamin C and cancer chemoprevention: reappraisal", Am J Clin Nutr, 78, pp.1074~1078 (2003)
53. Levine M, "A new recommended dietary allowance of vitamin C for healthy young women", Proc Natl Acad Sci U S A, 98, pp.9842~9846 (2001)
54. Hahm E, "The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma", J Cell Biochem, 102, pp.1002~1010 (2007)
55. Kang JS, "L-ascorbic acid (vitamin C) induces the apoptotic of B16 murine melanoma cells via a caspase-8-independent pathway", Cancer Immunol Immunother, 52, pp.693~698 (2003)
56. Kim JE, "Vitamin C inhibits p53-induced replicative senescence through suppression of ROS production and p38 MAPK activity", Int J Mol Med, 22, pp.651~655 (2008)
57. Lee SK, "Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase (COX-2) expression and the modulation of insulin-like growth factor (IGF-II) production", J Cell Physiol, 216, pp.180~188 (2008)
58. Ashino H, "Novel function of ascorbic acid as an angiostatic factor", Angiogenesis, 6, pp.259~269 (2003)
59. Chen Q, "Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice", Proc Natl Acad Sci U S A, 105, pp.11105~11109 (2008)
60. Chen Q, "Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid In vivo", Proc Natl Acad Sci U S A, 104, pp.8749~8754 (2007)
61. White JD, "Complementary and alternative medicine research:a National Cancer institue perspective", Semin Oncol, 29, pp.546~551 (2002)
62. Nahin RL, "Use of the best case series to evaluate complementary and alternative therapies for cancer: a systematic review", Semin Oncol, 29, pp.552~562 (2002)
63. Padayatty SJ, "Intravenously administered vitamin C as cancer therapy: three cases", CMAJ, 174, pp.937~942 (2006)